Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009
See this aricle in Pubmed

Article Abstract
These drugs alter the immune response at different sites, and most, if not all, affect more than one aspect of host immunity. Drawing from existing experience with the use of these immunomodulatory therapies in other conditions and that available from the limited experience with multiple sclerosis, we review their potential untoward effects. The latter include a predisposition to opportunistic and community-acquired infections, an altered response to vaccination, the development of cancers, and the appearance of autoimmune diseases. The identification of progressive multifocal leukoencephalopathy as a risk of therapy is relatively straightforward in light of its rarity and high morbidity and mortality, but a relatively slight increased risk for more common and less disabling disorders may be overlooked. Determining the actual risk frequency for many of these complications will likely require careful postmarketing surveillance.
 
Related Tags
(click to filter results - removes previous filter)

adverse drug reaction
carcinoma
central nervous system,infection of
cladribine
complications
fingolimod
iatrogenic neurologic disorders
immunosuppressive agents
JC virus
lymphoma
monoclonal antibodies
multiple sclerosis
multiple sclerosis,treatment of
natalizumab
opportunistic infection
opportunistic infection,CNS
progressive multifocal leucoencephalopathy
risk factors
treatment of neurologic disorder
vaccination,neurologic complications with
vaccine
viral infection
viral infection,CNS

Click Here to return To Results